Genelux (GNLX) Research & Development (2022 - 2026)
Genelux (GNLX) posted Research & Development of $5.78 million for Q1 2026, up 23.0% from $4.7 million a year earlier and up 2.2% from the prior quarter.
Powered by 
Analysis
Genelux (GNLX) Research & Development (2022 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Research & Development at Genelux was $20.93 million, up 6.3% year-over-year; for FY2025, it was $19.85 million, up 4.5% from FY2024.
- Annual Research & Development has increased for three consecutive years, with a three-year compound annual growth rate of 29.8% (FY2022 to FY2025).
- In prior years, Genelux's Research & Development was $19 million in FY2024 (+48.8%), $12.77 million in FY2023 (+40.6%) and $9.08 million in FY2022.
- The Q1 2026 figure stands as the highest quarterly Research & Development since Q4 2024.
- On a year-over-year basis, Research & Development increased in seven of the last eight quarters, with growth averaging 25.3%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2023, with growth of 68.6%; the weakest was Q4 2025, with a decline of 13.3%.
- According to Business Quant data, Research & Development for the three prior quarters was $5.65 million (Q4 2025), $4.74 million (Q3 2025) and $4.76 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Genelux | 91.17 Mn | 29.45 Mn | - | 5.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.78 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Jun 30, 2025 | 4.76 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 6.52 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 4.42 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 4.16 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Jun 30, 2023 | 2.94 Mn |
| Mar 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 2.47 Mn |
| Sep 30, 2022 | 2.41 Mn |
API Access
Genelux Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GNLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GNLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GNLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();